Merz Therapeutics and the World Stroke Organization launch the Access to Health Initiative for the Improvement of Schlaganfallversorgung in Africa

• Offizielle Vorstellung of Initiative “Access to Health” (“Zugang zu Gesundheit”) at the World Stroke Congress during the President of the WSO, Dr. Sheila Martins
• The Partnership will continue to exist, the Ungleichheiten in der Gesundheitsversorgung durch Pilotprojekte in Nigeria und Tansania zu verringern
• Project leaders and health experts take care of the following, the writing and project sustainability of your design

World Stroke Organization (WSO) President Dr Sheila Martins, at the World Stroke Congress in Abu Dhabi, has launched a partnership with more therapies and an “Access to Health” initiative. These projects have begun to develop independence in general health care in the states with new and mittlerem Einkommen (LMICs) that could start with pilot projects in Nigeria and Tansania.

Während der Veranstaltung kamen Projektleiter aus all Wereld alles Samen, een nächsten Schritte and de strategic Ausrichtung dies innovative Partnerschaft zu besprechen. “There is an unclear conclusion, the mission of one of the patients in general healthcare can be expanded,” said Stefan König, CEO of Merz Therapeutics. “Our collaboration with the World Stroke Organization is a reality, the urgency is to promote disease control in the region with good infrastructure for development.”

The initiative deals with the critical problems of the schlagan fallversorgung in those regional areas, while the schlaganfallhäufigkeit is high, underexposed in the young population groups. The area of ​​the Schlaganfallfälle in sub-Saharan Africa is dramatically different, with a yearly income rate of 316 deaths for 100,000 people and a 3-year death rate of over 80%. A small difficulty in carrying out rehabilitation facilities and medical treatment Fachpersonal verschärfen de Krise weiter¹

Pilot program in Nigeria and Tanzania

In Nigeria, the initiative focuses on the initiation of chapters in the schlaganfallversorgung by the Verbesserung der Aus- und Weiterbildung of neurologists and medical professionals. There is a quick way to complete the Bildungsmodule of the Rehabilitation Program after a Schlaganfall. The soul is that the Fähigkeit der Fachkräfte are erweitern, Schlaganfallmanagement und -rehabilitation op de nouvelle Stand der Technik-anzubiten.

In Tansania, the initiative has started to help patients solve the problems of providing resources for their skills. At the end of the best use of the WSO line, you can carry out more strategic therapeutic analyzes at the Weiterentwicklung of the infrastructure for the Schlaganfall treatment beets, especially by the Unterstützung of Schlaganfallstationsen in Krankenhäusern. Merz Therapeutics strives to provide healthcare for patients and a local community service that is supported, comprehensive and multidisciplinary care for a universal community of people.

Schaffung nachhaltiger Lösungen für die Gesundheitsversorgung

Launched in 2023, the “Access to Health” initiative is part of Merz Therapeutics’ umphasing strategy, healthcare in LMICs through debt for personal medical, patient-centered, strategic partnerships and leisure in healthcare delivery. While treatment with the WSO may enable more therapies, the well-known answers will be possible, a side effect, which provides a solution to one or more economic barriers, so that you can receive a high level of medical care.

“Our long-term concern is that there is a healthy lifestyle in healthcare, which will promote disease control in the regions and healthcare in the region,” said Stefan Albrecht, Chief Scientific and Medical Officer of Merz Therapeutics. “This initiative shortens our commitment, the common justice and for all zugänglicher zu machen.”

Uber Merz therapies

Merz Therapeutics GmbH is responsible for treating patients* in the world of healthcare. If you find a disinterested research and a solution for your innovation, it can be the best, an unanswered concern for patients* that you want to recognize and that justice will get. This involves people in the heart, who suffer from treatment disorder, neurological disorders, cerebral hemorrhages and others, which cause serious serious health problems.

Merz Therapeutics operates in Hauptsitz in Frankfurt am Main, Germany, and is active in more than 90 states. Die Tochtergesellschaft in North America in Sitz in Raleigh, North Carolina. Die Merz Therapeutics GmbH is part of the Merz Group, a privately owned family, which sits on 115 years of the Entwicklung of Innovationen-widmet, an unsatisfied patient*inbed for addressing.

More at www.merztherapeutics.com.

About the World Stroke Organization

The World Stroke Organization (WSO) is the prosperous organization in the camp of creating a disease and the fact that it is so that the global attack by the disease will continue through the growth, education and interests of the company. The WSO organization with national organizations and organizations of one-sided organization, an organization concerned with combating the disease and the prosperity it prevents.

¹ Akinyemi, RO, Ovbiagele, B., Adeniji, OA, Sarfo, FS, Abd-Allah, F., Adoukonou, T., Ogah, OS, Naidoo, P., Damasceno, A., Walker, RW, Ogunniyi, A ., Kalaria, RN, Owolabi, MO (2021). Stroke in Africa: Profile, Progress, Prospects and Priorities. Nature reviews. Neurology, 17(10), 634-656. https://doi.org/10.1038/s41582-021-00542-4

The general text, in the original text which is light, is the official and authorized version. The settings need to be adjusted. Nur de Sprachversion, de originale veröffentlichte wurde, is legalgültig. Use the original version of the view ab.

Original version on businesswire.com as follows: https://www.businesswire.com/news/home/20241024370697/de/

Contacts:

Merz Therapeutics GmbH

Agnes Tesch

Global communication

+49 69 1503 2129

[email protected]